LYKA LABS
|
The Current P/S Ratio of LYKA LABS is 1.97.
| Share Price | ₹75.4 | Jan 28,2026 |
| Market Cap | ₹269.1 Cr | |
| Sales-TTM | ₹136.9 Cr | TTM-Consolidated Results |
| Price/Sales | 1.97x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LYKA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹269.1 Cr] as on Jan 28,2026
(/) Sales [ ₹136.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.97x ]
Thus, for LYKA LABS , the investors are currently willing to pay '1.97 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LYKA LABS !
The chart below summarizes the trend in P/S Ratio of LYKA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of LYKA LABS
PS Ratio Performance Analysis for LYKA LABS
- LYKA LABS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.41x.
- LYKA LABS 's operated at median p/e ratio of 2.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2023 at 3.45x.
- LYKA LABS 's p/e ratio hit its five-year low in Mar2021 of 0.86x.
How does LYKA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LYKA LABS | 136.9 | 1.97 | 269.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.03 | 386,329.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.42 | 164,674.0 |
| CIPLA LTD | 28,351.1 | 3.78 | 107,292.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.93 | 133,891.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.95 | 102,184.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.43 | 87,333.0 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.68 | 90,218.9 |
| LUPIN LTD | 24,750.7 | 3.92 | 96,952.6 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.04 | 66,220.1 |
| ABBOTT INDIA LTD | 6,714.4 | 8.73 | 58,634.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LYKA LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.97x |
| Max industry PS | 16.42x |
| Median industry PS | 3.92x |
| Average industry PS | 6.17x |
You may also like the below Video Courses